Download
Download by
Scanning QR Code
  • Download app

    Download app

  • Online Inquiry

    Log in to access Online Inquiry
+
Congratulations
You've successfully got advanced quotes worth 5000 HKD
Download APP >>
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Futubull > Quotes > 02137 BRII-B > Detailed Quotes

02137 BRII-B

Watchlist
8.460
-0.300-3.42%
Closed 06/30 16:08 CCT
High
8.820
Open
8.720
Turnover
50.40M
Low
8.360
Pre Close
8.760
Volume
5.89M
Market Cap
6.11B
P/E(TTM)
Loss
52wk High
52.600
Shares
722.60M
P/E(Static)
Loss
52wk Low
7.150
Float Cap
6.11B
Bid/Ask %
13.48%
Historical High
52.600
Shs Float
722.60M
Volume Ratio
1.03
Historical Low
7.150
Dividend TTM
--
Div Yield TTM
--
P/B
1.50
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.81%
Amplitude
5.25%
Avg Price
8.560
Lot Size
500
Float Cap
6.11B
Bid/Ask %
13.48%
Historical High
52.600
Shs Float
722.60M
Volume Ratio
1.03
Historical Low
7.150
Dividend TTM
--
P/B
1.50
Dividend LFY
--
Turnover Ratio
0.81%
Amplitude
5.25%
Avg Price
8.560
Lot Size
500
Price Forecast

No Data

News

Comment

Company Overview More
Tengsheng Boyao Biotechnology Co., Ltd. is a biotechnology company headquartered in China and the United States, mainly engaged in infectious disease therapy research and development business. The company's products are used in infectious diseases (such as hepatitis B virus (HBV), human immunodeficiency virus (HIV), multidrug-resistant (MDR) or extensively drug-resistant (XDR) Gram-negative bacteria infections) and other diseases with significant public health burdens, such as central nervous system (CNS) diseases. The company also develops treatments for COVID-19 and others.
CEO: Zhi HONG
Market: Hong Kong motherboard
Futu Hot List
HKUSCN
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist
Back to the Top